Shares of TransMedics Group swung into positive territory in Monday’s late-trading session, after the medical-technology company reported fourth-quarter financial results.
After the bell, the stock had gained 19%, to $92.54. The stock closed the day’s regular session at $77.74, down 6.5%.
TransMedics reported fourth-quarter earnings per share of 12 cents on revenue of $81.2 million. In the prior-year period, the company reported a loss per share of 21 cents on revenue of $31.4 million.
The company also said it “expects total revenue for full-year 2024 to be in the range of $360 million to $370 million, which represents 49% to 53% growth compared to the company’s prior year revenue.”